PEELED INTERNAL LIMITING MEMBRANE REPOSITION
PEELED INTERNAL LIMITING MEMBRANE REPOSITION FOR IDIOPATHIC MACULAR HOLES: A Single-centre, Randomized, Prospective Controlled Trial
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
90 participants
Apr 15, 2024
INTERVENTIONAL
Conditions
Summary
Macular hiatus (MH) refers to a tissue defect in the photoreceptor cell layer of the inner boundary membrane of the optic disc in the macular region. Among them, idiopathic macular hiatus (IMH) is more common in people over 60 years old and is a common eye disease. With the aging of society, the number of patients increases, and it severely damages the patients' vision and life quality. Previously, the conventional surgical approach for treating MH was vitrectomy combined with inner limiting membrane (ILM) peeling. Although the closure rate of MH is high, many damages to the morphology and function of the ILM peeled area have been found. Our team firstly report a novel technique of peeled ILM reposition. Compared to traditional ILM peeling, the novel technique peeled ILM reposition maintains the integrity of internal retina by "pull" back the ILM flap. The previous pilot clinical study suggests that the novel technique peeled ILM reposition surgical intervention can achieve better morphology and functional prognosis. However, there is currently a lack of larger sample size prospective randomized controlled studies to further clarify the clinical efficacy of this new surgical technique in treating IMH. This study aims to conduct a single center, prospective, and randomized controlled study, combined with previous work, to analyze the efficacy of this novel technique peeled ILM peeling in the treatment of IMH. We hypothesize that this novel technique can achieved better morphological and functional prognosis compared to traditional ILM peeling.
Eligibility
Inclusion Criteria4
- The patients are diagnosed as MH with a diameter ≤ 600 µm by optical coherence tomography.
- Age ranges from 50 to 80 years.
- Do not participate in other clinical studies.
- Agree to sign an informed consent form with good compliance.
Exclusion Criteria8
- Traumatic macular hole.
- Combined with serious epiretinal membrane.
- Combined with diabetic retinopathy, hypertensive retinopathy.
- Combined with other ocular diseases, such as keratitis,uveitis,retinal vasculitis.
- Spherical equivalent ≥ -6.0 diopters or axial length ≥ 26 mm.
- History of intraocular surgery.
- Presence of staphyloma.
- Other ocular diseases that influence macular microstructure or visual function.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The ILM was stained using 0.1 mL of indocyanine green(ICG) for approximately 1minute after PPV. The ILM was grasped with end gripping forceps (Grieshaber Maxgrip 723.13; Alcon Laboratories Inc) at a point away from the center of MH around one disc diameter in inferior quadrant of macular area. First, a horizontal ILM strip was peeled off with a width approximately 1.5 to 2.5 disc diameter. Then, the edge of the horizontal ILM strip was grasped and peeled from inferior to superior area continuously.Then the "ILM roll" was flattened back to peeled area assisted with approximately 1.0 mL of PFO (Perfluoron, Alcon Laboratories, Inc). The position of the fixed ILM flap was adjusted under PFO bubble using flute needle or forceps if required.
The ILM was stained using 0.1 mL of indocyanine green(ICG) for approximately 1minute after PPV. The ILM was grasped with end gripping forceps (Grieshaber Maxgrip 723.13; Alcon Laboratories Inc). The strand of ILM was peeled off radially from the foveal center to the vascular arcade. As a result, a round-shaped, 2.5-disk diameter to 3.5-disk diameter ILM-peeled area was created.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06359548